Methylene blue reversal of ifosfamide-related encephalopathy

J Pediatr Hematol Oncol. 2004 Feb;26(2):116. doi: 10.1097/00043426-200402000-00010.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / adverse effects*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary
  • Child
  • Electroencephalography
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Ifosfamide / adverse effects*
  • Magnetic Resonance Imaging
  • Male
  • Methylene Blue / therapeutic use*
  • Neurotoxicity Syndromes / diagnosis
  • Neurotoxicity Syndromes / drug therapy*
  • Neurotoxicity Syndromes / etiology
  • Osteosarcoma / drug therapy
  • Osteosarcoma / secondary
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents, Alkylating
  • Enzyme Inhibitors
  • Methylene Blue
  • Ifosfamide